• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Establishment of novel cellular therapy for hemophilia A using autologous blood outgrowth endothelial progenitors

Research Project

Project/Area Number 22790995
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeSingle-year Grants
Research Field Pediatrics
Research InstitutionNara Medical University

Principal Investigator

MATSUI Hideto  奈良県立医科大学, 医学部, 講師 (00571027)

Project Period (FY) 2010 – 2011
Project Status Completed (Fiscal Year 2011)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2010: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywords小児血液学 / 血友病A / 血管内皮前駆細胞 / レンチウイルスベクター / 遺伝子治療 / 細胞療法 / イヌモデル
Research Abstract

We have established ex vivo gene transfer system using genetically-modified blood outgrowth endothelial progenitor cells(BOECs) which are capable of synthesizing therapeutic levels of plasma FVIII over a prolonged time periods.^<20> Using this ex vivo gene transfer strategy, we can provide for the safe and efficacious delivery of FVIII following subcutaneous implantation of BOECs in hemophilia A mouse model. Now, we would like to try this strategy in hemophilia A dog model.

Report

(3 results)
  • 2011 Annual Research Report   Final Research Report ( PDF )
  • 2010 Annual Research Report
  • Research Products

    (15 results)

All 2012 2011 2010

All Journal Article (6 results) (of which Peer Reviewed: 2 results) Presentation (9 results)

  • [Journal Article] Endothelial progenitor cell-based therapy for hemophilia A2012

    • Author(s)
      Matsui H
    • Journal Title

      International Journal of Hematology

      Volume: 95(2) Pages: 119-124

    • NAID

      10030267050

    • Related Report
      2011 Annual Research Report 2011 Final Research Report
  • [Journal Article] microRNA制御レンチウイルスベクターによる肝臓特異的第VIII因子誘導:血友病Aインヒビターに対する新規免疫寛容導入アプローチ2011

    • Author(s)
      松井英人
    • Journal Title

      日本血栓止血学会誌

      Volume: 22(6) Pages: 377-383

    • Related Report
      2011 Final Research Report
  • [Journal Article] A microRNA-regulated and GP64-pseudotyped lentiviral vectors mediated stable expression of FVIII in murine model of hemophilia A2011

    • Author(s)
      Matsui H, Hegadorn C, Ozelo M, Burnett E, Tuttle A, Labelle A, McCray PB Jr, Naldini L, Brown B, Hough C, Lillicrap D
    • Journal Title

      Molecular Therapy

      Volume: 19(4) Pages: 723-730

    • Related Report
      2011 Final Research Report
  • [Journal Article] microRNA制御レンチウイルスベクターによる肝臓特異的第VIII因子発現誘導:血友病Aインヒビターに対する新規免疫寛容導入アプローチ2011

    • Author(s)
      松井英人
    • Journal Title

      日本血栓止血学会誌

      Volume: 22(6) Pages: 377-383

    • NAID

      10031144656

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Characterization of viability and proliferation of alginate-poly-L-lysine alginate encapsulated myoblasts using flow cytometry2010

    • Author(s)
      Thakur A, Sengupta R, Matsui H, Lillicrap D, Jones K, Hortelano G
    • Journal Title

      Journal of Biomedecal Material Research

      Volume: 94B(2) Pages: 296-304

    • Related Report
      2011 Final Research Report
  • [Journal Article] Characterization of viability and proliferation of alginate-poly-L-lysine-alginate encapsulated myoblasts using flow cytometry.2010

    • Author(s)
      Thakur A, et.al.
    • Journal Title

      Journal of Biomedical Materials Research B : Applied Biomaterials

      Volume: 94(2) Pages: 296-304

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Presentation] Immune tolerance induction to FVIII in hemophilia A using autologous endothelial progenitors2011

    • Author(s)
      Hideto Matsui, David Lillicrap, Mitsuhiko Sugimoto, Midori Shima
    • Organizer
      The 2nd Meeting of Asian Cellular Therapy Organization
    • Place of Presentation
      Miyazaki, Japan
    • Year and Date
      2011-10-19
    • Related Report
      2011 Final Research Report
  • [Presentation] Immune tolerance induction to FVIII in hemophilia A using autologous endothelial progenitors2011

    • Author(s)
      Hideto Matsui, et.al.
    • Organizer
      The 2^<nd> meeting of ACTO
    • Place of Presentation
      Miyazaki, Japan
    • Year and Date
      2011-10-18
    • Related Report
      2011 Annual Research Report
  • [Presentation] 自己血管内皮前駆細胞移植による血友病Aインヒビターに対する新規免疫寛容導入療法2011

    • Author(s)
      松井英人、David Lillicrap、杉本充彦、嶋緑倫
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋市
    • Year and Date
      2011-10-16
    • Related Report
      2011 Annual Research Report 2011 Final Research Report
  • [Presentation] Stem cell-based gene therapy for hemophilia A2011

    • Author(s)
      Hideto Matsui
    • Organizer
      The 7^<th> Aso International Meeting
    • Place of Presentation
      Kumamoto, Japan
    • Year and Date
      2011-07-30
    • Related Report
      2011 Annual Research Report 2011 Final Research Report
  • [Presentation] Long-term phenotypic correction of hemophilia A mice following injection of miRNA-regulated lentiviral vectors2010

    • Author(s)
      Hideto Matsui, David Lillicrap, Mitsuhiko Sugimoto, Midori Shima
    • Organizer
      6^<th> Congress of the Asia Pacific Society on Thrombosis and Haemostasis
    • Place of Presentation
      Bali, Indonesia
    • Year and Date
      2010-10-14
    • Related Report
      2011 Final Research Report
  • [Presentation] Long-term phenotypic correction of hemophilia A mice following injection of miRNA-regulated lentiviral vectors.2010

    • Author(s)
      Matsui H, et.al.
    • Organizer
      6^<th> Congress of the Asia Pacific Society on Thrombosis and Haemostasis
    • Place of Presentation
      Bali, Indonesia
    • Year and Date
      2010-10-14
    • Related Report
      2010 Annual Research Report
  • [Presentation] Sustained therapeutic levels of FVIII activity from lentivirally-engineered blood outgrowth endothelial cells requires cell stability and augmented angiogenesis2010

    • Author(s)
      Hideto Matsui, Margareth Ozelo, Andrea Labelle, Carol Hegadorn, Patrick Thompson, Erin Burnnet, Christine Hough, David Lillicrap
    • Organizer
      The 13^<th> Annual Meeting of American Society of Gene and Cell Therapy
    • Place of Presentation
      Washington DC, USA
    • Year and Date
      2010-05-21
    • Related Report
      2011 Final Research Report
  • [Presentation] Sustained therapeutic levels of FVIII activity from lentivirally-engineered blood outgrowth endothelial cells requires cells stability and augmented angiogenesis.2010

    • Author(s)
      Matsui H, et.al.
    • Organizer
      The 13^<th> Annual Meeting of American Society of Gene and Cell Therapy
    • Place of Presentation
      Washington DC, U.S.A
    • Year and Date
      2010-05-21
    • Related Report
      2010 Annual Research Report
  • [Presentation] 第VIII因子発現レンチウイルスベクターによる血友病Aインヒビターに対する新規免疫寛容療法2010

    • Author(s)
      松井英人, 杉本充彦, デービット・リリクラップ, 柴田優, 嶋緑倫
    • Organizer
      第33回日本血栓止血学会学術集会
    • Place of Presentation
      鹿児島市
    • Year and Date
      2010-04-23
    • Related Report
      2011 Final Research Report 2010 Annual Research Report

URL: 

Published: 2010-08-23   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi